P53 gene mutations in chronic myelogenous leukemia medullary and extramedullary blast crisis

Leuk Lymphoma. 1996 Dec;24(1-2):175-82. doi: 10.3109/10428199609045726.

Abstract

Molecular alterations of the P53 gene were investigated in 27 unselected patients with chronic myelogenous leukemia (CML) blast crisis. A rearrangement of the P53 gene was evident by Southern blotting in 3 cases, one of which also showed the same alteration in the chronic phase. Single strand conformation polymorphism and sequencing analysis showed point mutations in 4 blast crisis cases. Of interest, P53 point mutations were evident in all the 3 cases of extramedullary blast crisis examined and the same point mutation was found in the myeloblastoma tissues and in the subsequent peripheral blast cells. These data indicate that: a) P53 gene mutations occur in a significant but not a large number of CML acute phase cases; b) P53 gene point mutations seem to correlate strongly with the infrequent extramedullary presentation of the blast crisis; c) the presence of the same P53 gene point mutation in extramedullary and bone marrow blast cells confirms the common clonal origin of the two cellular populations.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blast Crisis*
  • Blotting, Northern
  • Blotting, Southern
  • Bone Marrow Diseases / genetics*
  • Bone Marrow Diseases / pathology
  • Disease Progression
  • Gene Rearrangement
  • Genes, p53*
  • Humans
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology
  • Point Mutation*
  • Polymerase Chain Reaction / methods
  • Polymorphism, Single-Stranded Conformational
  • Sequence Analysis, DNA